Greg Sempowski

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter

Filter by Year

Search Results

Sources of variability in Luminex bead-based cytokine assays: Evidence from twelve years of multi-site proficiency testing

Initiator cell death event induced by SARS-CoV-2 in the human airway epithelium

The TLR2/TLR6 ligand FSL-1 mitigates radiation-induced hematopoietic injury in mice and nonhuman primates

A new class of antibodies that overcomes a steric barrier to cross-group neutralization of influenza viruses

Transient inhibition of lysosomal functions potentiates nucleic acid vaccines

Evaluation of SARS-CoV-2 identification methods through surveillance of companion animals in SARS-CoV-2-positive homes in North Carolina, March to December 2020

Development and validation of an automated assay for anti-drug-antibodies in rat serum

H3N2 influenza hemagglutination inhibition method qualification with data driven statistical methods for human clinical trials

COVID-19 diagnosis and SARS-CoV-2 strain identification by a rapid, multiplexed, point-of-care antibody microarray

Long-term immunological consequences of radiation exposure in a diverse cohort of rhesus macaques

An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2

Nebulized mRNA-encoded antibodies protect hamsters from SARS-CoV-2 infection

An epitope-enriched immunogen expands responses to a conserved viral site

An antibody from single human VH-rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5 by inhibiting membrane fusion

Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine

Targeted dose delivery of Mycobacterium tuberculosis in mice using silicon antifoaming agent via aerosol exposure system

Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy

Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infection

A virion-based combination vaccine protects against influenza and SARS-CoV-2 disease in mice

Differential chromatin accessibility in peripheral blood mononuclear cells underlies COVID-19 disease severity prior to seroconversion